Search Results
Dec 09, 2025, 08:34 ET Brave Healer Productions Announces the Release of Joy Unleashed: The Ultimate Guide to Living Your Best Life
of 24 co-authors writing about keeping the spark of joy alive even in difficult circumstances.BETHESDA, Md., Dec. 9, 2025 /PRNewswire/ -- Brave Healer Productions announces the release of
More news about: Brave Healer Productions
Dec 09, 2025, 08:15 ET Potomac Bank Voted 2025 "Best of the Best" Bank, Financial Planning, Loan Service, and Mortgage Company by Journal-News Readers
an additional eight branch offices, and two loan production offices. Offices are located in Jefferson and Berkeley Counties (WV), Washington County (MD), and Loudoun and Stafford Counties (VA). The Bank offers commercial lines and term loans, residential and commercial construction loans, commercial
More news about: Potomac Bank
Dec 09, 2025, 08:00 ET Oral Presentation at ASH 2025 Shows Canopy RTM Cuts Infection-Related Hospitalizations by 52% and Generates Nearly $1M in Annual Savings per 1,000 Patients
benchmarks.¹"What stands out in this study is how often patients with hematologic malignancies reported symptoms before an acute event," said Benjamin Derman, MD, presenting author and Assistant Professor of Medicine at the University of Chicago Medicine. "Those reports frequently preceded the need for infection-related
More news about: Canopy
Dec 09, 2025, 08:00 ET Vincere Cancer Center Begins Recruitment for Clinical Studies of Pioneering Breast Cancer Screen for Women at High Risk
machine learning algorithms to detect breast cancer at hyper-early stage.Vincere is part of a multi-center study led by Massimo Cristofanilli, MD, at Weill Cornell Medicine in collaboration with Professor Kristina Rinker, PhD, co-Principal Investigator at the University of Calgary and Cofounder
More news about: Syantra Inc.
Dec 09, 2025, 08:00 ET Texas ER Doctor Shares Safety Tips to Keep Young Children Out of the Emergency Room This Christmas
decorate trees, wrap presents, and prepare to hit the road for holiday family gatherings, Texas emergency room physician, Dr. Christopher L Huerta, MD, is urging parents of infants, toddlers, and young children to keep safety at the top of their Christmas list.
More news about: SignatureCare Emergency Centers
Dec 09, 2025, 08:00 ET Jensen Hughes Announces Acquisition of Safety Management Services, Inc.
expands Jensen Hughes' global expertise in energetic materials, compliance and risk solutionsCOLUMBIA, Md., Dec. 9, 2025 /PRNewswire/ -- Jensen Hughes, a global leader in fire & life safety, security and risk-based
More news about: Jensen Hughes
Dec 09, 2025, 07:30 ET Pirtobrutinib Outperforms Bendamustine Plus Rituximab for Previously Untreated CLL/SLL
"We were able to prove that pirtobrutinib is an excellent drug both in terms of efficacy and tolerance," said lead study author Wojciech Jurczak, MD, PhD, professor of hematology at the National Research Institute of Oncology in Kraków, Poland. "Our data show that it is not just overcoming resistance
More news about: American Society of Hematology
Dec 09, 2025, 07:30 ET Drug Reduced Need for Blood Transfusions During Hospitalization for Non-Cardiac Surgery
that TXA reduces the need for blood transfusion in patients undergoing higher-risk non-cardiac surgery," said lead study author Brett Houston, MD, PhD, an assistant professor at the University of Manitoba and a scientist with the Paul Albrechtsen Research Institute in Winnipeg, Canada.
More news about: American Society of Hematology
Dec 09, 2025, 07:30 ET Tec-Dara Combination Offers Substantial Improvement Over Standard Second-Line Therapies for Relapsed or Refractory Multiple Myeloma
myeloma."We were surprised by the efficacy data because we didn't expect such a magnitude of benefit," said lead study author María-Victoria Mateos, MD, PhD, physician in the haematology department and professor of medicine at the University of Salamanca in Spain. "These are the best data we've seen
More news about: American Society of Hematology
Dec 09, 2025, 07:30 ET Novel Agent Ianalumab Added to Standard Therapy Extends Time to Treatment Failure in Patients with Previously Treated Immune Thrombocytopenia
provided long-term disease control with no need for chronic therapy and no increase in infection risk," said lead study author Hanny Al-Samkari, MD, the Peggy S. Blitz Endowed Chair in Hematology/Oncology at Mass General Brigham Cancer Institute and an associate professor of medicine at Harvard
More news about: American Society of Hematology
Dec 09, 2025, 07:30 ET Recordati Rare Diseases Announces Real-World Data on Long-Term Safety of ENJAYMO® (sutimlimab-jome) in Cold Agglutinin Disease and Cold Agglutinin Syndrome (CAD/CAS) at American Society of Hematology (ASH) Annual Meeting
agglutinin syndrome, offering a unique, real-world view of how patients respond to long-term therapy," said lead investigator Catherine M. Broome, MD, Professor of Medicine and Director of Cellular Apheresis at the Lombardi Cancer Center at MedStar Georgetown University in Washington, DC. "Our
More news about: Raliance Communications
Dec 09, 2025, 07:30 ET Lilly's Jaypirca (pirtobrutinib) significantly improved progression-free survival, reducing the risk of progression or death by 80%, versus chemoimmunotherapy in patients with treatment-naïve CLL/SLL
significant effect size, among the most pronounced ever observed for a single agent BTK inhibitor in a front-line CLL study," said Wojciech Jurczak, MD, PhD, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland. "The magnitude of the progression-free survival benefit, early overall
More news about: Eli Lilly and Company
Dec 09, 2025, 07:00 ET Saluda Medical Raises $150M USD to Fuel Growth Following ASX IPO
were zero explants due to loss of efficacy."Saluda's technology is a true paradigm shift in the world of neuromodulation," said Jason E. Pope, MD, Founder & CEO, Evolve Restorative Center, Santa Rosa, CA, USA. "By delivering closed-loop stimulation, pulse by pulse, tailored to each individual
More news about: Saluda Medical
Dec 09, 2025, 06:03 ET Taylor Morrison Recognized in Newsweek's America's Most Responsible Companies 2026 List for Fourth Consecutive Year
Home Edition." Team members and trade partners built five homes for deserving families and a Wellness Center for a community of homes for Banner MD Anderson Cancer Center patients.Taylor Morrison's disclosures align with the material topics highlighted by the Sustainability Accounting
More news about: Taylor Morrison
Dec 09, 2025, 06:00 ET Realtor.com®: A 73.2% Spike in Monthly Payments For Moving Traps U.S. Homeowners in Place
smallest lock-in effects include:Pittsburgh, Penn.: Homeowners face a 32.5% increase in monthly payments.Baltimore, Md.: The increase is 34.0%.Buffalo, N.Y.: The gap stands at 34.8%."While low-cost markets offer the smallest penalty for moving, they
More news about: Realtor.com
Dec 09, 2025, 06:00 ET Lucile Packard Children's Hospital Stanford Celebrates Top Maternity Care Honors for Fifth Straight Year
Yasser El-Sayed, MD, division chief of maternal-fetal medicine and obstetrics at Stanford Medicine and Ford Family Endowed obstetrician-in-chief at Lucile Packard Children's
More news about: Stanford Medicine Children's Health and Lucile Packard Children's Hospital Stanford
Dec 09, 2025, 06:00 ET Providence Medical Technology, Inc. Announces Compatibility of CORUS-GLX™ System with Globus Medical's Excelsius™ Navigation System for Posterior Lumbar Fusion
procedures.Streamlined surgical workflow, potentially leading to shorter operative times and reduced risk of complications.James Dowdell, MD, an Orthopedic Surgeon at Hospital for Special Surgery and Instructor of Orthopedic Surgery at Weill Cornell Medical College, commented, "Integrating
More news about: Providence Medical Technology, Inc.
Dec 09, 2025, 05:00 ET Dizal Showcases its Strong Hematology Pipeline with New Data from Golidocitinib and Birelentinib at ASH 2025
CHOP, showed an ORR of 88.9% and a CR rate of 61.1% R/R PTCLAn updated 2-year follow-up from the MD Anderson Cancer Center cohort of the multinational pivotal trial JACKPOT8 Part B showed that golidocitinib monotherapy in patients with relapsed or refractory
More news about: Dizal Pharmaceutical
Dec 09, 2025, 02:00 ET Colliers Secures Full Ownership of India Business to Accelerate Growth and Market Leadership
https://mma.prnewswire.com/media/2841388/Badal_Yagnik_CEO_MD_Colliers_India.jpgLogo: https://mma.prnewswire.com/media/2667399/5662459/Colliers_Logo.jpg
More news about: Colliers
Dec 08, 2025, 19:00 ET Innovent Announces PECONDLE® (Picankibart Injection) Phase 3 Study (CLEAR-2) Meets Endpoints, Delivering Superior Long-Term Management Solution for Moderate-to-Severe Psoriasis
in early clinical stage. Innovent partners with over 30 global healthcare companies, including Eli Lilly, Sanofi, Takeda, Incyte, Adimab, LG Chem and MD Anderson Cancer Center.Guided by the motto, "Start with Integrity, Succeed through Action," Innovent maintains the highest standard of industry
More news about: Innovent Biologics
Dec 08, 2025, 18:20 ET The Inner Circle acknowledges, James W. Edlund, MD as a Pinnacle Lifetime Member
FORT WAYNE, Ind., Dec. 8, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle, James W. Edlund, MD is recognized as a Pinnacle Lifetime Member for his contributions as a Distinguished Surgeon and Medical Director Advancing Wound Care Excellence.
More news about: The Inner Circle
Dec 08, 2025, 18:20 ET The Inner Circle acknowledges Ilene Fennoy, MD, MPH, as a Pinnacle Professional Member Inner Circle of Excellence
NEW YORK, Dec. 8, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle, Ilene Fennoy, MD, MPH is acknowledged as a Pinnacle Professional Member Inner Circle of Excellence for her contributions to Pediatric Endocrinology and Child Health Advocacy.
More news about: The Inner Circle
Dec 08, 2025, 16:15 ET Vapotherm and Flight Medical Announce Partnership to Bring the VentO2ux™ Ventilator to US Hospitals
Departments."Clinicians tell us every day that they need tools that are simple to use, reliable, and focused on patient comfort." said Jessica Whittle, MD, PhD, Chief Medical Officer at Vapotherm. "By adding VentO2ux to our product line, we are extending Vapotherm's legacy of patient comfort focused respiratory
More news about: Vapotherm, Inc.
Dec 08, 2025, 15:17 ET Le groupe Menarini présente les données de la phase 2 sur l'association d'Elacestrant (ORSERDU®) chez des patientes atteintes d'un cancer du sein métastatique (mBC) ER+, HER2- lors du 2025 San Antonio Breast Cancer Symposium
le cadre d'une association », a déclaré Virginia Kaklamani, MD, DSc, professeur de médecine dans la division hématologie/oncologie à UT Health San Antonio et responsable du programme de lutte contre le cancer du sein à UT Health San Antonio MD Anderson Cancer Center. « Le profil de sécurité de l'élacestrant
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 08, 2025, 14:47 ET Menarini Group präsentiert Daten zur Phase-2-Kombination von Elacestrant (ORSERDU®) bei Patientinnen mit ER+, HER2- metastasiertem Brustkrebs (mBC) auf dem San Antonio Breast Cancer Symposium 2025
Kombinationsbehandlung spielen könnte", sagte Virginia Kaklamani, MD, DSc, Professorin für Medizin in der Abteilung für Hämatologie/Onkologie an der UT Health San Antonio und Leiterin des Brustkrebs-Programms am UT Health San Antonio MD Anderson Cancer Center. „Das Sicherheitsprofil von Elacestrant in
More news about: Menarini Industrie Farmaceutiche Riunite